Physician profile
Anthony J Stephens
NPI 1831184431
$3,995.64
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,549 · 2020: $434 · 2021: $12.56.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,280.21 | 2019 | |
| Alexion Pharmaceuticals, INC. | $390.78 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $303.47 | 2019-2020 | |
| Ucb, INC. | $297.90 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $235.81 | 2019 | |
| Biogen, INC. | $204.61 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $196.07 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $167.97 | 2019-2020 | |
| Genentech USA, INC. | $141.77 | 2019-2020 | |
| Lundbeck LLC | $106.35 | 2019-2020 | |
| Lilly USA, LLC | $85.66 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $83.88 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $72.76 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $64.59 | 2019-2020 | |
| Zyla Life Sciences, INC. | $55.54 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $48.33 | 2019-2020 | |
| Genzyme Corporation | $47.82 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $42.43 | 2019 | |
| Emd Serono, INC. | $36.54 | 2019 | |
| Grifols USA, LLC | $31.66 | 2019 | |
| Amgen INC. | $21.03 | 2019 | |
| Mdd US Operations, LLC | $20.09 | 2020 | |
| Pfizer INC. | $16.79 | 2019 | |
| Abbvie INC. | $16.43 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.18 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.97 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.